There are many applications that are available today that could be brought into the oncology landscape to create a much more patient-centered focus of experiences for those undergoing care, said Susan Dentzer, senior policy fellow at the Duke-Margolis Center for Health Policy.
There are many applications that are available today that could be brought into the oncology landscape to create a much more patient-centered focus of experiences for those undergoing care, said Susan Dentzer, senior policy fellow at Robert J. Margolis Center for Health Policy at Duke University.
Transcript
Based on your session at ACCC 46th Annual Meeting & Cancer Center Business Summit, can you discuss some examples of disruptive innovations within cancer care delivery?
When we think about innovation, in cancer care delivery, or for that matter, innovation going on all across healthcare, we think largely about the possibility of moving care outside of more conventional institutional settings, to more what we could call—distributed settings. So, homes, communities, work sites, etc. We know that's happening across a lot of health care, particularly through telemedicine. The question is how much of that is applicable to the field of cancer care?
You think about cancer care, and you think, well, that mainly involves laying on of hands—you've got to be in an institution to have surgery done, you've got to be in an institution have chemo, etc; but the question is, what about all the other aspects of cancer care that don't involve those things that are laying out of hands? How much of that can happen outside of institutional settings? The answer is quite a lot, quite a lot, but it doesn't tend to happen even though we know that patients would probably be happier when they could be in the community or at home.
We know that there's a lot of need for information that patients need on a regular basis and they need to be exchanging information with their care providers. What symptoms am I having? How am I reacting to my chemotherapy? Do I have emotional needs? Or other social support needs that need to be met to enable me to live my life with cancer. All of those areas really are applicable now for innovations around telehealth around telegenetics, tele-palliative care. There are many applications now that are available today that could be brought into the system really to create a much more patient focused set of experiences for patients.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More